FMP
XOMA Corporation
XOMA
NASDAQ
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
27.13 USD
2.02 (7.45%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Owen P. Hughes Jr.
sector
Healthcare
industry
Biotechnology
website
https://www.xoma.comexchange
NASDAQ
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
CIK
0000791908
ISIN
US98419J2069
CUSIP
98419J206
Address
2200 Powell Street
Phone
510 204 7200
Country
US
Employee
13
IPO Date
Jun 6, 1986
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
XOMA Financial Summary
CIK
0000791908
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
98419J206
ISIN
US98419J2069
Country
US
Price
27.13
Beta
0.9
Volume Avg.
27.84k
Market Cap
319.66M
Shares
-
52-Week
17.8-35.0
DCF
-2.07
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-8.84
P/B
-
Website
https://www.xoma.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest XOMA News
It looks like there's no news available.
